Abstract:ObjectiveLeukocyte immunoglobulin‐like receptor A3 belongs to a family of receptors with inhibitory or activating functions. Since Caucasian individuals lacking LILRA3 have been found to be susceptible to multiple sclerosis and Sjögren's syndrome, we undertook this study to examine whether LILRA3 deletion is a novel genetic risk factor for rheumatoid arthritis (RA) (another autoimmune disease), whether there are sex‐specific effects, and whether LILRA3 influences the subtype and severity of RA.MethodsThe LILRA3 deletion and its tagging single‐nucleotide polymorphism rs103294 were genotyped in a Northern Han Chinese cohort (N‐Han) (1,618 cases and 1,658 controls) and a Southern Han Chinese cohort (S‐Han) (575 cases and 549 controls). Association analyses were performed on the complete data set and subsets. The effect of the nondeleted (functional) LILRA3 allele on radiographic severity and LILRA3 expression was evaluated.ResultsIn the N‐Han discovery cohort, we unexpectedly observed a higher frequency of the functional LILRA3 in RA patients compared with healthy individuals (10.1% versus 6.3%; P = 4.01 × 10−5, odds ratio [OR] 1.92). The association was replicated in the S‐Han cohort and confirmed by meta‐analysis (P = 5.63 × 10−6, OR 1.83). Functional LILRA3 conferred greater risk for RA in males (P = 1.09 × 10−6, OR 4.47), and was specifically associated with anti–citrullinated protein antibody (ACPA)–positive RA (P = 3.05 × 10−4, OR 1.75). Furthermore, functional LILRA3 was associated with higher radiographic scores in ACPA‐positive patients with early RA (P = 9.70 × 10−3) and higher LILRA3 messenger RNA levels (P = 3.31 × 10−8).ConclusionOur study provides the first evidence that functional LILRA3 is a novel genetic risk factor for RA, especially in males. It appears to highly predispose to ACPA‐positive RA and confers an increased risk of disease severity in patients with early RA.

AB0101 Impact on Bone Destruction by LILRA3: A High Risk Susceptible Gene in Rheumatoid Arthritis

The Molecular Mechanisms of Androgen Receptor in Nephrolithiasis.

The Role of Interleukin-17 in Mediating Joint Destruction in Rheumatoid Arthritis

The pro-inflammatory effect of NR4A3 in osteoarthritis

Impact Of The Leucocyte Immunoglobulin-Like Receptor A3 (Lilra3) On Susceptibility And Subphenotypes Of Systemic Lupus Erythematosus And Sjogren'S Syndrome

Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.

Long Non-Coding RNA AL928768.3 Promotes Rheumatoid Arthritis Fibroblast-Like Synoviocytes Proliferation, Invasion and Inflammation, While Inhibits Apoptosis Via Activating Lymphotoxin Beta Mediated NF-κB Signaling Pathway.

Leukocyte Ig-like Receptor A3 Facilitates Inflammation, Migration and Invasion of Synovial Tissue-Derived Fibroblasts Via ERK/JNK Activation.

The correlation between interleukin-34 and bone erosion under ultrasound in rheumatoid arthritis

Soluble LILRA3 is Aberrantly Expressed in Antiphospholipid Syndrome (APS) and is a Potential Marker of Thrombotic APS

RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry

TNF-α-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis

Identification of new susceptibility loci associated with rheumatoid arthritis

Comprehensive Bioinformatics Analysis Reveals Hub Genes and Inflammation State of Rheumatoid Arthritis

Effect of Rheumatoid Arthritis Associated HLA-DRβ1 Subtypes on Protein Kinase A Signaling

MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis

Genome-Wide Association Studies to Drug: Identifying Retinoic Acid Metabolism Blocking Agents to Suppress Mechanoflammation in Osteoarthritis

LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation

Impact of rheumatoid arthritis-associated HLA-DRβ1 subtypes on protein kinase A signaling

Genomic and Serological Rheumatoid Arthritis Biomarkers, MUC5B Promoter Variant, and Interstitial Lung Abnormalities

MYLKFLNB and DOCK1LAMA2 gene–gene interactions associated with rheumatoid arthritis in the focal adhesion pathway